A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences

Gene Therapy

Volumn 18, Issue 4, 2011, Pages 364-371

  Romero, Z ^a   Torres, S ^a   Cobo, M ^a   Muoz P ^a   Unciti, J D ^a   Martin F ^a   Molina, I J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

activation inducible vectors; CD40L promoter; hyper IgM syndrome; lentiviral vectors; tissue specific vectors; transcriptional targeting

Indexed keywords

CD40 LIGAND; LENTIVIRUS VECTOR;

ARTICLE; CELL ACTIVATION; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYPER IGM SYNDROME; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; STEM CELL; T LYMPHOCYTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

CD40 LIGAND; CELL LINE; GENE THERAPY; GENETIC VECTORS; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; LENTIVIRUS; LYMPHOCYTE ACTIVATION; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

ANIMALIA;

EID: 79953771894     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.144     Document Type: Article

References (32)

1. Thrasher AJ. Gene therapy for primary immunodeficiencies. Immunol Allergy Clin North Am 2008; 28: 457-471, xi. (Pubitemid 351522852)
2. Aiuti A, Roncarolo MG. Ten years of gene therapy for primary immune deficiencies. Hematology Am Soc Hematol Educ Program 2009: 682-689.
3. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419. (Pubitemid 37296260)
4. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143-3150.
5. Prioleau MN, Nony P, Simpson M, Felsenfeld G. An insulator element and condensed chromatin region separate the chicken beta-globin locus from an independently regulated erythroid-specific folate receptor gene. EMBO J 1999; 18: 4035-4048. (Pubitemid 29335856)
6. Rincon-Arano H, Furlan-Magaril M, Recillas-Targa F. Protection against telomeric position effects by the chicken cHS4 beta-globin insulator. Proc Natl Acad Sci USA 2007; 104: 14044-14049. (Pubitemid 350003332)
7. Werner M, Kraunus J, Baum C, Brocker T. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcrip-tional regulatory element. Gene Ther 2004; 11: 992-1000. (Pubitemid 38923623)
8. Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood 2003; 101: 3416-3423. (Pubitemid 36857923)
9. Martin F, Toscano MG, Blundell M, Frecha C, Srivastava GK, Santamaria M et al. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences. Gene Ther 2005; 12: 715-723. (Pubitemid 40561509)
10. Frecha C, Toscano MG, Costa C, Saez-Lara MJ, Cosset FL, Verhoeyen E et al. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis. Gene Ther 2008; 15: 930-941. (Pubitemid 351791480)
11. Lagasse E, Connors H, Al Dhalimy M, Reitsma M, Dohse M, Osborne L et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229-1234.
12. Camargo FD, Green R, Capetanaki Y, Jackson KA, Goodell MA. Single hematopoietic stem cells generate skelet al muscle through myeloid intermediates. Nat Med 2003; 9: 1520-1527. (Pubitemid 38004780)
13. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; 6: 532-539. (Pubitemid 38786596)
14. Toscano MG, Frecha C, Benabdellah K, Cobo M, Blundell M, Thrasher AJ et al. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein. Hum Gene Ther 2008; 19: 179-197. (Pubitemid 351271509)
15. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993; 90: 2170-2173. (Pubitemid 23078587)
16. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003; 82: 373-384. (Pubitemid 37445041)
17. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992; 22: 2573-2578.
18. Castle BE, Kishimoto K, Stearns C, Brown ML, Kehry MR. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol 1993; 151: 1777-1788. (Pubitemid 23235651)
19. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996; 14: 591-617. (Pubitemid 26130658)
20. Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest 1999; 103: 1151-1158. (Pubitemid 29207249)
21. Brown MP, Topham DJ, Sangster MY, Zhao J, Flynn KJ, Surman SL et al. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 1998; 4: 1253-1260. (Pubitemid 28512105)
22. Sacco MG, Ungari M, Cato EM, Villa A, Strina D, Notarangelo LD et al. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. Cancer Gene Ther 2000; 7: 1299-1306.
23. Tsytsykova AV, Tsitsikov EN, Geha RS. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 1996; 271: 3763-3770. (Pubitemid 26065696)
24. Cron RQ. CD154 transcriptional regulation in primary human CD4T cells. Immunol Res 2003; 27: 185-202.
25. Schubert LA, Cron RQ, Cleary AM, Brunner M, Song A, Lu LS et al. A T cell-specific enhancer of the human CD40 ligand gene. J Biol Chem 2002; 277: 7386-7395. (Pubitemid 34953135)
26. Brunner M, Zhang M, Genin A, Ho IC, Cron RQ A. T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter. Genes Immun 2008; 9: 640-649.
27. Ford GS, Barnhart B, Shone S, Covey LR. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol 1999; 162: 4037-4044. (Pubitemid 29314786)
28. Tahara M, Pergolizzi RG, Kobayashi H, Krause A, Luettich K, Lesser ML et al. Tr a n s -splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency. Nat Med 2004; 10: 835-841. (Pubitemid 39070857)
29. Dunn RJ, Luedecker CJ, Haugen HS, Clegg CH, Farr AG. Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization. J Histochem Cytochem 1997; 45: 129-141. (Pubitemid 27045373)
30. Molina IJ, Kenney DM, Rosen FS, Remold-O'Donnell E. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 1992; 176: 867-874.
31. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813. (Pubitemid 34493974)
32. Schubert LA, King G, Cron RQ, Lewis DB, Aruffo A, Hollenbaugh D. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J Biol Chem 1995; 270: 29624-29627. (Pubitemid 26002152)